Michael P. DeMartino

Author

Also Known As

DeMartino, M.P., DeMartino, Michael P., Joshua P. Taygerly, M. DeMartino, Michael DeMartino, Michael P. DeMartino, Michael P. Martino, Michael P. DeMartino

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)Scripps Research Institute University of Oklahoma Health Sciences Center WuXi AppTec (China)

About

Michael P. DeMartino is an author at GlaxoSmithKline (United States) specializing in medicine, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	700
2	Engineering	3	3	285
3	Natural Sciences	2	2	218
4	Biochemistry	2	2	92
5	Biomolecular Engineering	2	2	270

Michael P. DeMartino

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity Pratyusha Mandal, Scott B. Berger, Sirika Pillay, Molecular Cell Cell RegulationPronecrotic Kinase ActivityReceptor Tyrosine KinaseApoptosisAutophagy	2014	593
Intermolecular Enolate Heterocoupling: Scope, Mechanism, and Application Michael P. DeMartino, Ke Chen, Phil S. Baran Journal of the American Chemical Society	2008	295
Intermolecular Oxidative Enolate Heterocoupling Phil S. Baran, Michael P. DeMartino Angewandte Chemie International Edition Diversity Oriented SynthesisEngineeringNatural SciencesDiversity-oriented SynthesisTotal Synthesis	2006	198
Intermolecular Oxidative Enolate Heterocoupling Phil S. Baran, Michael P. DeMartino Angewandte Chemie EngineeringEine Rasche SyntheseBiochemistryMedicineLignane Wie	2006	72
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel Pamela A. Haile, Linda Casillas, Michael J. Bury, ACS Medicinal Chemistry Letters	2018	35
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS Hilary S. Eidam, John P. Russell, Kaushik Raha, ACS Medicinal Chemistry Letters	2018	32
Titanium(IV) Isopropoxide Mediated Synthesis of Pyrimidin-4-ones Joshi M. Ramanjulu, Michael P. DeMartino, Yunfeng Lan, Organic Letters	2010	29
Applications of Model-Based Target Pharmacology Assessment in Defining Drug Design and DMPK Strategies: GSK Experiences Emile P. Chen, Robert W. Bondi, Carolyn Zhang, Journal of Medicinal Chemistry Drug TargetDefining Drug DesignPhysiologically-based Pharmacokinetic ModelingPharmacodynamic ModelingGsk Experiences	2022	20
Enteric RET inhibition attenuates gastrointestinal secretion and motility via cholinergic signaling in rat colonic mucosal preparations John P. Russell, Ehsan Mohammadi, Casey O. Ligon, Neurogastroenterology & Motility	2018	18
Model-Based Virtual PK/PD Exploration and Machine Learning Approach to Define PK Drivers in Early Drug Discovery Emile P. Chen, Shayoni Dutta, Ming‐Hsun Ho, Journal of Medicinal Chemistry Drug TargetEngineeringHit IdentificationMachine Learning ApproachPreclinical Efficacy Models	2024	15

Page 1